MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81160281, 81441083, 81660405)
- Jiangxi Province Talent 555 Project (20152ACB20024)
- National Natural Science Foundation of Jiangxi Province (20152ACB20024, 20151BBG70228)
- JiangXi Province Postgraduate Special Innovation Fund (YC2016-S101)
- Nanchang University (0902-0210210802)
- JiangXi Province General Project (20171BBG70121)
- Youth Scientific Funds-Youth Fund Project (20171BAB215041)
- JiangXi Province Education Fund Project (700653002)
This publication has 32 references indexed in Scilit:
- Hippo‐YAP signaling pathway: A new paradigm for cancer therapyInternational Journal of Cancer, 2014
- A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric CancerCancer Cell, 2014
- Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitroBiochemical and Biophysical Research Communications, 2014
- Epigenetic Regulation of microRNAs in Gastric CancerDigestive Diseases and Sciences, 2013
- Function and cancer genomics of FAT family genesInternational Journal of Oncology, 2012
- Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genesNature Genetics, 2012
- The Tumor Suppressor RASSF1A Prevents Dephosphorylation of the Mammalian STE20-like Kinases MST1 and MST2Journal of Biological Chemistry, 2011
- Mst1/2 signalling to Yap: gatekeeper for liver size and tumour developmentBritish Journal of Cancer, 2010
- Molecular evolution of the cadherin superfamilyThe International Journal of Biochemistry & Cell Biology, 2009
- Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)Journal of Biological Chemistry, 2008